Several brokerages have updated their recommendations and price targets on shares of Alibaba Group (NYSE: BABA) in the last few weeks: 5/27/2026 – Alibaba Group had its “hold (c+)” rating reaffirmed by Weiss Ratings. 5/23/2026 – Alibaba Group was upgraded by Wall Street Zen from “sell” to “hold”. 5/15/2026 – Alibaba Group had its price […]

Several brokerages have updated their recommendations and price targets on shares of Denali Therapeutics (NASDAQ: DNLI) in the last few weeks: 5/22/2026 – Denali Therapeutics had its price target lowered by Morgan Stanley from $40.00 to $35.00. They now have an “overweight” rating on the stock. 5/22/2026 – Denali Therapeutics was given a new $31.00 […]

Birkenstock (NYSE: BIRK) recently received a number of ratings updates from brokerages and research firms: 5/22/2026 – Birkenstock had its “buy” rating reaffirmed by The Goldman Sachs Group, Inc.. They now have a $52.50 price target on the stock. 5/15/2026 – Birkenstock was downgraded by Zacks Research from “hold” to “strong sell”. 5/14/2026 – Birkenstock […]

Omada Health (NASDAQ: OMDA) recently received a number of ratings updates from brokerages and research firms: 5/8/2026 – Omada Health had its “buy” rating reaffirmed by The Goldman Sachs Group, Inc.. 5/8/2026 – Omada Health had its “outperform” rating reaffirmed by Evercore Inc. They now have a $20.00 price target on the stock. 5/8/2026 – […]

Several brokerages have updated their recommendations and price targets on shares of Societe Generale Group (OTCMKTS: SCGLY) in the last few weeks: 5/26/2026 – Societe Generale Group had its “buy” rating reaffirmed by Deutsche Bank Aktiengesellschaft. 5/21/2026 – Societe Generale Group was downgraded by Zacks Research from “hold” to “strong sell”. 5/15/2026 – Societe Generale […]

Forum Markets (NASDAQ: FRMM) has recently received a number of price target changes and ratings updates: 5/16/2026 – Forum Markets was downgraded by Wall Street Zen from “hold” to “sell”. 5/15/2026 – Forum Markets had its price target raised by Benchmark Co. from $5.00 to $9.00. They now have a “speculative buy” rating on the […]

A number of firms have modified their ratings and price targets on shares of Energy Transfer (NYSE: ET) recently: 5/26/2026 – Energy Transfer was upgraded by Jefferies Financial Group Inc. from “hold” to “buy”. They now have a $23.00 price target on the stock. 5/14/2026 – Energy Transfer had its “overweight” rating reaffirmed by Barclays […]

Realty Income (NYSE: O) has recently received a number of price target changes and ratings updates: 5/13/2026 – Realty Income had its price target lowered by Mizuho from $68.00 to $66.00. They now have a “neutral” rating on the stock. 5/12/2026 – Realty Income had its “outperform” rating reaffirmed by Scotiabank. 5/12/2026 – Realty Income […]

Several brokerages have updated their recommendations and price targets on shares of Alkermes (NASDAQ: ALKS) in the last few weeks: 5/13/2026 – Alkermes had its price target raised by Robert W. Baird from $45.00 to $48.00. They now have an “outperform” rating on the stock. 5/11/2026 – Alkermes was downgraded by Weiss Ratings from “hold […]

Arthur J. Gallagher & Co. (NYSE: AJG) has recently received a number of price target changes and ratings updates: 5/21/2026 – Arthur J. Gallagher & Co. was given a new $240.00 price target by UBS Group AG. 5/21/2026 – Arthur J. Gallagher & Co. had its price target lowered by Morgan Stanley from $265.00 to […]

Several analysts have recently updated their ratings and price targets for Hewlett Packard Enterprise (NYSE: HPE): 5/21/2026 – Hewlett Packard Enterprise had its price target raised by Morgan Stanley from $25.00 to $33.00. They now have an “equal weight” rating on the stock. 5/17/2026 – Hewlett Packard Enterprise was downgraded by Wall Street Zen from […]

Several brokerages have updated their recommendations and price targets on shares of Summit Therapeutics (NASDAQ: SMMT) in the last few weeks: 5/21/2026 – Summit Therapeutics is now covered by Sanford C. Bernstein. They set an “underperform” rating on the stock. 5/18/2026 – Summit Therapeutics was downgraded by Wall Street Zen from “hold” to “sell”. 5/10/2026 […]

Several brokerages have updated their recommendations and price targets on shares of Humacyte (NASDAQ: HUMA) in the last few weeks: 5/16/2026 – Humacyte was upgraded by Wall Street Zen from “strong sell” to “sell”. 5/13/2026 – Humacyte had its price target lowered by BTIG Research from $3.00 to $2.00. They now have a “buy” rating […]

A number of research firms have changed their ratings and price targets for Zimmer Biomet (NYSE: ZBH): 5/9/2026 – Zimmer Biomet was upgraded by Wall Street Zen from “hold” to “buy”. 4/29/2026 – Zimmer Biomet was given a new $83.00 price target by Canaccord Genuity Group Inc.. 4/29/2026 – Zimmer Biomet was given a new […]